SCHEMBL28065098

SCHEMBL28065098

CC(C)(C)OC(=O)NC(C)(CCO)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.43
NAALAD2 Q9Y3Q0 1/20 0.43
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
CTSK P43235 9/20 0.36
CTSS P25774 7/20 0.36
CA1 P00915 3/20 0.35
CA7 P43166 3/20 0.35
CA2 P00918 2/20 0.35
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CA12 O43570 3/20 0.33
CA14 Q9ULX7 3/20 0.33
APLNR P35414 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4911352 0.89 TDP1 (0.53) TDP1NAALAD2MEN1GAAKMT2A
SCHEMBL9067717 0.89 TDP1 (0.53) TDP1NAALAD2MEN1GAAKMT2A
SCHEMBL28168389 0.85 NAALAD2 (0.43) TDP1NAALAD2MEN1GAAKMT2A
SCHEMBL2258655 0.85 DGAT1 (0.44) TDP1MEN1GAAKMT2ACTSK
SCHEMBL2258658 0.85 DGAT1 (0.44) TDP1MEN1GAAKMT2ACTSK
SCHEMBL2129742 0.85 TDP1 (0.42) TDP1NAALAD2MEN1GAAKMT2A
SCHEMBL201901 0.85 TDP1 (0.42) TDP1NAALAD2MEN1GAAKMT2A
SCHEMBL1486204 0.85 TDP1 (0.42) TDP1NAALAD2MEN1GAAKMT2A
SCHEMBL15619294 0.84 NAALAD2 (0.42) TDP1NAALAD2MEN1GAAKMT2A
SCHEMBL8971824 0.84 NAALAD2 (0.65) TDP1NAALAD2MEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105646637-B A kind of abiraterone derivative and preparation method thereof and medical usage 四川海思科制药有限公司 2018-12-14 CN disclosed
CN-105646637-A Abiraterone derivative, preparation method and medical applications thereof 四川海思科制药有限公司 2016-06-08 CN disclosed